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Abstract Endogenous opioids have been implicated in me-
diating (placebo) analgesia, in reward processes, and in the
regulation of socially relevant emotions. To explore their
potential contributions to higher cognitive functions, we used
a novel task with tachistoscopically presented (for 150 ms)
pairs of meaningless figures. Healthy right-handed men
judged the similarities and dissimilarities between the two
figures on a visual analogue scale (VAS) in two separate runs.
In a double-blind, between-subjects design, subjects were
administered intravenously either 0.2-mg/kg naloxone or pla-
cebo 10 min prior to the task, and VAS judgments and re-
sponse latencies were measured. We found a significant
interaction between substance group and type of judgment:
The magnitude of the similarity judgments was lower in the
naloxone than in the placebo group, while dissimilarity judg-
ments remained uninfluenced by the treatment. Reaction la-
tencies and mood scores, assessed before and after substance
administration, did not differ between the two groups, indi-
cating that the findings did not rely on altered motor perfor-
mance or motivation. We suggest that naloxone decreased the
“similarity criterion” in comparative judgments, indicating its
potentially modulatory effect on visual cognition. The task
introduced here could be used for the implicit study and
quantification of subtle affective–cognitive processes beyond
the level of mere questionnaire data.
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Endogenous opioid systems have mainly been implicated in
affective processes, such as the response to reward (Smith &
Berridge, 2007), the modulation of endocrine functions (e.g.,
Drolet et al., 2001), the regulation of affect (e.g., Zubieta et al.,
2003), pleasure-related analgesia (Kut et al., 2011; Leknes &
Tracey, 2008) and the mediation of (placebo) analgesia (e.g.,
Petrovic, Kalso, Petersson, & Ingvar, 2002). Moreover, sev-
eral lines of evidence have indicated that the neurocircuitry
and neurochemistry of physical pain overlap with those of
more abstract, complex cognitive–affective experiences, such
as social emotions (Macdonald & Leary, 2005; Stein, van
Honk, Ipser, Solms, & Panksepp, 2007). Indeed, the endoge-
nous opioid systems’ involvement in social attachment and
social distance regulation was demonstrated in pioneering
studies by Panksepp in a separation distress paradigm with
animals (Herman & Panksepp, 1978; Panksepp, Herman,
Vilberg, Bishop, & DeEskinazi, 1980), and subsequently in
genetic studies with mouse pups (Moles, Kieffer, & D’Amato,
2004) and infant primates (Barr et al., 2008). While opiates
and opioids were demonstrated to be very effective in reduc-
ing social separation-induced distress, opiate antagonists such
as naloxone appear to increase separation distress (Herman &
Panksepp, 1978; Panksepp et al., 1980). In a recent neuroim-
aging study with healthy subjects, Eisenberger, Lieberman,
and Williams (2003) showed that neural networks activated
during distress caused by social exclusion are also activated
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during physical pain, and that pain experience can be reduced
by visual stimuli signaling attachment (Eisenberger et al.,
2011). In line with these findings of “social distance regula-
tion” is the general explanation for the feeling of physical pain
that accompanies emotional loss (Panksepp, 2003), whether it
be the loss of a loved one (Zubieta et al., 2003), rejection by
one’s social group (Eisenberger, 2012; Eisenberger, Jarcho,
Lieberman, & Naliboff, 2006; Eisenberger et al., 2003), or the
distress experienced by young animals when being separated
from their parents (Panksepp, 1998).
In healthy humans, opioid agonists have been implicated in
feelings of emotional relatedness or social emotions and in
mood-elevating effects (Gospic et al., 2008; Koepp et al.,
2009; Schaffer, Nordahl, Schaffer, & Howe, 2007). By con-
trast, the mu-opioid antagonist naloxone has been shown to
influence endocrine functions (Drolet et al., 2001) and occa-
sionally reported to induce dysphoric mood states at doses
over 0.25 mg/kg (Grevert, Albert, Inturrisi, & Goldstein,
1983; Martin del Campo, Dowson, Herbert, & Paykel, 1994;
Martin del Campo, McMurray, Besser, & Grossman, 1992;
Mendelson, Ellingboe, Keuhnle, & Mello, 1978). However, it
remains to be established how far the discrepancies in study
findings may be a consequence of the lack of a reliable
measure and methodological difficulties.
Most surprisingly, besides the reported opioidergically
modulated mood effects, a relative lack of studies have inves-
tigated influences on other higher brain functions. The excep-
tions are naloxone-dependent alterations in attention (Arnsten,
Neville, Hillyard, Janowsky, & Segal, 1984; Arnsten et al.,
1983; Buchsbaum et al., 1982) and memory (Cohen, Cohen,
Weingartner, Pickar, & Murphy, 1983; Friswell et al., 2008;
Kamboj, Tookman, Jones, & Curran, 2005). More recently,
Biederman and colleagues suggested that mu-opioids are in-
volved in perceptual pleasure (Biederman & Vessel, 2006;
Yue, Vessel, & Biederman, 2007). In fact, a high density of
mu-opioid receptors in the brains of macaque monkeys (Lewis
et al., 1981; Wise & Herkenham, 1982) was found in associ-
ation areas, such as the parahippocampal cortex, and distrib-
uted along a gradient that increased in density along the ventral
visual pathway. Similar mu-receptor distributions in the ven-
tral visual pathway were found in the human brain (Hiller &
Fan, 1996; Peckys & Landwehrmeyer, 1999; Quirion &
Pilapil, 1991). However, their influence on cognitive judg-
mental processes has been largely unexplored. Endogenous
opioids’ influence on cognitive functioning is thus of central
importance for both basic and clinical research (see Ersek,
Cherrier, Overman, & Irving, 2004, for a clinical review).
From a phenomenological perspective, a cognitive equiv-
alent to emotional feelings of relatedness, or more broadly to
“social emotions,” could be conceptualized as “coherence
perception,” social distance regulation, or the appreciation of
(dis)similarity between two different stimuli. Theories about
coherence perception (e.g., Ashby & Perrin, 1988; Solan &
Ruppin, 2001) aim at explaining why and when people judge
two different stimuli as being related. Judgments of
similarity/dissimilarity are an important, but often neglected,
component in a variety of cognitive processes. Processes of
coherence perception—in particular, similarity—are involved
in object recognition (Barenholtz & Tarr, 2008), decision
making (Kim, Novemsky, & Dhar, 2013), visual attention
(Duncan & Humphreys, 1989), analogic reasoning (Novick,
1988), belief formation (Gianotti, Mohr, Pizzagalli, Lehmann,
& Brugger, 2001), semantic and perceptual categorization
(Pettigrew, 1958), and aesthetics (Wertheimer, 1923/1958).
In the semantic domain, coherence perception is influenced
by affective states (Balas, Sweklej, Pochwatko, &Godlewska,
2012; Estes, Jones, & Golonka, 2012). Spotting similarity has
also been proposed to be a fundamental aspect of various
cognitive processes, such as making inferences, knowledge
generalization, and knowledge transfer (e.g., Gentner,
Rattermann, & Forbus, 1993). Finally, similarity has also been
suggested to account for many different facets of social per-
ception and behavior, ranging from physical attraction (Byrne,
1971) and social comparison (Mussweiler, 2003) to interper-
sonal interaction (Tajfel, 1982) and group membership (e.g.,
Campbell, 1958).
Although the question of how people judge similarity and
dissimilarity is clearly of critical importance in social cogni-
tion (e.g., Mitchell, Macrae, & Banaji, 2006) and in cognitive
psychology, little is known about the neurochemical under-
pinnings of coherence perception or about whether it can be
considered a distinct cognitive system. We here introduce a
novel judgment task, assessing “cognitive relatedness” or
formal visual coherence/contrast perception. In a visual per-
ceptual task, we investigated whether a mu-opioid receptor
antagonist (naloxone) could modify healthy subjects’ judg-
ments of similarity/dissimilarity. Since we conceptualized co-
herence perception as a cognitive equivalent of social distance
regulation (feelings of relatedness), which has been associated
with the activity of endogenous opioid systems, we predicted
decreased similarity (coherence perception) and increased dis-
similarity (contrast perception) judgments in subjects receiv-
ing a naloxone injection. Especially since endogenous opioid
systems have been suggested as being involved in the visual
system. Moreover, we hypothesized a dissociation of similar-
ity and dissimilarity; that is, we assumed that they would not
represent two endpoints on a bipolar scale, but instead provide
two independent, context-dependent frames of reference.
Method
Subjects
The volunteers were 21 advertisement-recruited healthy right-
handed men (mean handedness score [Chapman & Chapman,
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1987] = 13.9, SD = 1.6, range = 13–19) 19–44 years of age
(M = 26.7 years, SD = 7.4). All subjects gave written in-
formed consent to the experimental procedures, which had
been approved by the local ethics committee.
The health status of the subjects was assessed with a
detailed questionnaire (Campbell, 2000). All subjects con-
firmed the absence of any relevant acute or chronic disease
(hypertension, heart disease, renal disease, liver disease,
mental illness, or seizure disorder) and of any history of
neurological disorder, mental illness, or mental impairment.
They also denied having a history of abuse of medications,
drugs, or alcohol and engaging in any recreational consump-
tion of drugs, narcotics, or other substances relevant to the
central nervous system over the last three months. They
were paid 50 Swiss francs for participation in the study.
Subjects were tested individually, seated on a comfortable
reclining chair in front of a 15.2-in. (diagonal) computer screen.
Room lighting and screen contrast were all kept constant.
The presentation of all instructions was carried out via
computer display and automatically controlled by “Superlab
Pro 4” (Cedrus) running on an Apple G4 Powerbook. The
distance between head and computer screen was adjusted to
permit undisturbed view and was kept at approximately
60 cm for all subjects.
Procedure
Questionnaire: measurement of subjects’ mood Subjects
rated their mood two times, once at the beginning and once
at the end of the experiment. Their ratings were assessed
with 24 adjectives from the German version of the
Multidimensional Mood Questionnaire (MDBF; Steyer,
Schwenkmezger, Notz, & Eid, 1997). The MDBF question-
naire is a short, multidimensional, self-evaluative question-
naire that describes the current mood state of an individual
on three dimensions: “good versus bad mood”, “wakeful-
ness versus sleepiness”, and “calmness versus restlessness”.
Similarity and dissimilarity judgment tasks A total of 18
different stimulus pairs, consisting of two horizontally placed
meaningless geometric figures, were tachistoscopically
presented bilaterally (exposure time = 150 ms). One figure
of a pair was presented to the left, and the other to the right
side of a central fixation cross (horizontal eccentricity = 1.5°
to 3.0° of visual angle). The single pairs were constructed to
respect the Gestalt laws of proximity, good continuation,
closure, similarity, and figure–ground properties. Each stimu-
lus pair was also presented in a vertically mirrored version.
The two counterbalanced runs each consisted of 36 trials (18
different stimulus pairs and 18 vertically mirrored versions of
each other); in one, subjects had to indicate similarity
(SJ: similarity judgment)—and in the other, dissimilarity
(DJ: dissimilarity judgment)—with a computer mouse in their
right hand on a 9-in. bipolar visual analogue scale (VAS)
presented against a light gray background (the sequential order
of each run in this paradigm is depicted in Fig. 1). All objects
(object size: within 2.8 × 2.8 cm, line thickness = 2 points)
were printed in black and presented on a computer screen
(gray background). Sample stimuli are illustrated in Fig. 1.
The stimulus pairs were identical in both the SJ and DJ runs
but were presented in a different, pseudorandomized order.
Subjects were asked to rest their head on a chinrest and to
fixate the cross in the center of the screen before and during
stimulus exposure (Fig. 1). They were instructed to respond
as quickly and intuitively as possible and were told that their
preference ratings on similarity/dissimilarity judgments
were highly subjective and that there were neither false
nor correct judgments.
Double-blind procedure for naloxone administration The
study had a randomized, double-blind, placebo-controlled,
between-subjects design. Either naloxone hydrochloride
(n = 10, 0.2 mg/kg body weight, concentration 1 mg/ml,
obtained from the pharmacy of Kanton Zürich) or the equiva-
lent volume of NaCl (n = 9, 0.9 %, also from the pharmacy of
Kanton Zürich) was administered. Similar naloxone dosages
had been previously shown to completely antagonize endoge-
nous opioid-mediated analgesia in healthy volunteers
(Amanzio & Benedetti, 1999). To prevent high stress levels
during the experiment, a nurse ran an intravenous catheter from
the inner elbow of the nondominant arm 10 min prior to drug
administration. The tasks were administered 10 min after drug
administration, since naloxone hydrochloride has a fast onset of
action (2min), but individual and dose-dependent times to peak
effect (from 5 to 15 min; Ngai, Berkowitz, Yang, Hempstead,
& Spector, 1976). In separate studies, its mean serum half-life
has been measured as 64 ± 12 min (Ngai et al., 1976) and
57 min (Berkowitz, Ngai, Hempstead, & Spector, 1975).
The entire testing was supervised by a medical doctor. All
subjects had been asked to refrain from any alcohol-,
caffeine-, or taurin-containing beverage for at least 12 h before
the start of the experiment and confirmed their compliance in
the debriefing. At the end of behavioral testing, the subjects
were asked (via questionnaire) which substance they thought
they had received.
Statistical analysis
Two separate two-way analyses of variance (ANOVAs) with
Substance Group (naloxone vs. placebo) as a between-
subjects factor and Run (similarity vs. dissimilarity rating) as
a repeated measure were calculated for positions on the VAS
(VAS magnitude, as percentages) and for reaction latencies.
The homogeneity of variances was checked using Levene’s
test (F = 1.775, p = .149), and the normal distribution of the
dependent variables was tested by the Kolmogorov–Smirnov
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test (Z ≤ .732, p ≥ .657). If not otherwise stated, all tests are
two-tailed with an α level of .05.
Outlier detection was performed by means of the Grubb
test. To test for a naloxone influence on psychometrically
assessed mood, a three-way repeated measures ANOVAwas
computed comprising the between-subjects factor Substance
Group (naloxone vs. placebo) and the within-subjects fac-
tors Time (beginning vs. end of the experiment) and Mood
Dimension (valence, wakefulness, calmness).
Two of the subjects did not adhere to the judgment task
instruction and constantly pressed the keyboard instead of
using the mouse to indicate the degree of similarity or dissim-
ilarity on the VAS. Valid data were thus available from 19 of
the subjects. No trials from any subject were excluded.
Results
Handedness, age, and blinding
The subjects in the naloxone and placebo groups did not
differ from one another in age [t(17) = −1.72, p = .11] and in
strength of right-handedness [t(17) = 1.78, p = .112].
We found no association between what substance
subjects believed they had received (drug or placebo)
and what they had actually received, which suggests
that the blinding was effective (χ2 = 0.532, p = .466):
Altogether, 84 % of the study subjects believed that
they had received saline. Two of the subjects who
thought they had received naloxone were in the placebo
group, and one subject under the influence of naloxone
correctly detected the substance.
Questionnaires
The mood ratings (MDBF) assessed at the beginning and the
end of the experiment did not differ significantly from each
other, nor were there any interactions with substance type
(all Fs ≤ 2.241, corresponding ps ≥ .122).
Cognitive judgment tasks
No significant main effects were found for VAS magnitudes
(all Fs ≤ 1.684, corresponding ps ≥ .212). However, the two-
way ANOVA for VAS magnitudes revealed a significant in-
teraction between substance group and run [F(1, 17) = 10.460,
Fig. 1 Time course of events in the similarity judgment run (SJ;
display A) and the dissimilarity judgment run (DJ; display B). After
750 ms (fixation of a central cross), a stimulus consisting of two
horizontally placed, meaningless geometric objects was bilaterally
exposed for 150 ms (balanced for object side order). Subsequently,
the degree of similarity or dissimilarity of the stimuli was rated by
clicking on the computerized visual analogue scale (VAS). In order to
control the baseline mouse position, subjects had to click on the
fixation cross in the middle of the screen after each judgment (which
elicited the next trial). Subjects were instructed to respond as quickly
and as intuitively as possible and to fixate their gaze on the cross in the
center of the screen
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p = .005; see Fig. 2]. The partial eta-squared effect size for this
interaction was .38 (Cohen’s d = 1.57).
Post hoc comparisons for this interaction showed a higher
VASmagnitude in the placebo group (M = 68.25, SD = 12.56)
than in the naloxone group (M = 57.09, SD = 6.30) for
similarity judgments (p = .023), but comparable VAS magni-
tudes between naloxone (M = 60.54, SD = 8.31) and placebo
(M = 60.17, SD = 14.30) for the dissimilarity judgments
(p = .945). Moreover, while the VAS magnitudes in the
placebo group were higher for similarity than for dissimilarity
judgments (p = .036), the VAS magnitudes for similarity and
dissimilarity in the naloxone group were not significantly
different from one another (p = .085).
Reaction latencies
No significant main effects or interactions were apparent (all
Fs ≤ 1.716, corresponding ps ≥ .208).
Discussion
Healthy subjects were administered a novel perceptual cogni-
tive judgment task assessing visual similarity and dissimilar-
ity. In a double-blind naloxone, placebo-controlled, between-
subjects design, we aimed to investigate the role of endoge-
nous opioids in “cognitive relatedness.” We focused on the
hypothesis that a cognitive equivalent to social distance regu-
lation might be conceptualized as “cognitive relatedness” and
could be dependent on mu-opioid receptor activity.
The results showed that the VAS magnitudes of similarity
judgments were more moderate for subjects in the naloxone
than in the placebo group; that is, visually presented stimulus
pairs were judged as being less similar under naloxone. For
judgments of dissimilarity, there was no analogous difference
between the placebo and naloxone groups. At first sight, these
finding could be interpreted as both supporting (in the case of
similarity judgments) and failing to support (in the case of
dissimilarity judgments) our hypothesis. However, we note an
asymmetry in judging two stimuli as “similar” or “dissimilar.”
Take the terms “ocean” and “lake,” for instance. While in
many ways these two notions are similar (both are bodies of
water and biotopes for fish, provide locations for holiday
resorts, modulate the microclimate, etc.), they are also distin-
guished by other properties (e.g., salt content). Accordingly,
our subjects’ similarity ratings were higher than their dissim-
ilarity judgments for the same stimulus pairs—but only in the
placebo group. Under naloxone, this primacy of seeing things
as similar was abolished.
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Fig. 2 Visual analogue scale
(VAS) magnitude scores (in
percentages) for the two
substance groups (naloxone,
placebo) and the two runs
(similarity, dissimilarity)
(means ± standard errors).
Because all subjects indicated
mean VAS scores above 50 %,
the illustrated scale range has
been adapted to be read from
50 % to 75 %. Asterisks (*)
indicate significant post-hoc
comparisons (p < .05)
Fig. 3 “Identical/opposite” ambigram created by the American graph-
ic designer Scott Kim in 1989. Image courtesy of the artist. © Scott
Kim, scottkim.com. Reproduced with permission
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Reaction latencies did not differ in the two groups. In
addition, psychometrically assessed mood did not differ
between the placebo and naloxone groups. Therefore, the
effects of altered VAS magnitudes are unlikely to simply
reflect naloxone-induced altered motor performance and/or
motivation, and thus were not confounded with the
operationalization of the cognitive judgments.
High similarity was perceived differently from low dis-
similarity, but only in the placebo, not the naloxone group.
VAS magnitudes were also more pronounced for similarity
than for dissimilarity.
We thus infer that the opioid antagonist naloxone de-
creased the “analogy criterion” in visual cognitive–affective
judgments, but only when framed in terms of similarity, not
dissimilarity. This finding points to a potential modulatory
effect of naloxone on judgments of cognitive relatedness
and suggests that some aspects of formal cognition—that is,
the readiness to judge something as similar and simulta-
neously as dissimilar—might be dependent on mu-opioid
receptor activity.
Clearly, although we did not find psychometrically
assessed mood differences between the placebo and nalox-
one groups, further research will need to test more directly
whether the altered cognitive strategies in similarity judg-
ments are mediated by naloxone-induced changes in the
affective system (i.e., a mildly detached or dysphoric mood)
or are the result of a specific, opioid-associated cognitive
focusing on formal stimulus properties perceived as being
related to one another. This could be done through the use of
more elaborated and combined, formally complex, and af-
fectively loaded visual stimuli, and by showing an accentu-
ation of similarity judgments under the influence of
opioidergic agonists. Most insightful would be a replication
of our approach using positron-emission tomography with
[(11)C]carfentanil (Zubieta et al., 2003) to measure possible
cortical regional mu-opioid receptor availability in vivo.
Indeed, a high density of mu-opioid receptors has been
found in the brains of macaque monkeys (Lewis et al.,
1981; Wise & Herkenham, 1982), and in human subjects
(Quirion & Pilapil, 1991), such receptors have been found to
be distributed along a gradient that increases in density
along the ventral visual pathway and in association areas
such as the parahippocampal cortex.
One may dare to surmise that distinct biological systems
are specifically involved in the neuronal generation of co-
herence perception. This type of relational perception, if it is
not a human equivalent of “social emotions” in animals
(Herman & Panksepp, 1978; Panksepp, 2003; Panksepp et
al., 1980), may arguably be at the heart of spotting similar-
ities in the objects, minds, and intentions that surround an
individual. Under this broad perspective, one further effect
uncovered in the present study deserves to be mentioned:
Judging two stimuli as being highly similar in the similarity
judgment run was no indicator of how dissimilar those same
stimuli would be perceived in the dissimilarity judgment
run. That is, the perception of relatedness, or “coherence
perception,” is by no means a homogeneous perceptual–
cognitive act. Rather, emphasis on resemblance and
unity may principally differ from a focus on distinctive
features of the scene or social interaction.
From a methodological point of view, classical self-report
measures of affective states have cast doubt on the reliability
of these measurements (e.g., Clark & Schober, 1992;
Tourangeau, Rips, & Rasinki, 2000). Our novel task could
provide a nonverbal, indirect, and sensitive cognitive measure
for the implicit study and quantification of subtle affective–
cognitive processes. It could likewise serve to characterize
pain judgments and evaluative reasoning beyond the level of
mere questionnaire data. To conclude, whether the glass is
judged as being half-full or half-empty may depend on the
rater’s balancing of positive and negative affect (see Fig. 3 for
an illustrative ambigram). The former tends to promote cog-
nitive “relational processes,” whereas the latter may inhibit
relational processing and narrow down the focus on stimulus-
specific processing (Clore & Palmer, 2008).
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